These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 17222396

  • 1. Serum carboxypeptidase A activity as a biomarker for early-stage pancreatic carcinoma.
    Matsugi S, Hamada T, Shioi N, Tanaka T, Kumada T, Satomura S.
    Clin Chim Acta; 2007 Mar; 378(1-2):147-53. PubMed ID: 17222396
    [Abstract] [Full Text] [Related]

  • 2. Serum procarboxypeptidase A and carboxypeptidase A levels in pancreatic disease.
    Kemik O, Kemik AS, Sumer A, Beğenik H, Dülger AC, Purisa S, Tuzun S.
    Hum Exp Toxicol; 2012 May; 31(5):447-51. PubMed ID: 21502183
    [Abstract] [Full Text] [Related]

  • 3. Confirmation of a potential biomarker for early-stage pancreatic cancer.
    Topilow AA, Davis JM, Vernick JJ, Tang D, Corbett S, Veltman T, Wagner SJ, Gilvarg C.
    Cancer Biomark; 2012 May; 10(1):27-33. PubMed ID: 22297549
    [Abstract] [Full Text] [Related]

  • 4. Serum heat shock protein 27 is increased in chronic pancreatitis and pancreatic carcinoma.
    Liao WC, Wu MS, Wang HP, Tien YW, Lin JT.
    Pancreas; 2009 May; 38(4):422-6. PubMed ID: 19214136
    [Abstract] [Full Text] [Related]

  • 5. Combined detection of serum tumor markers for differential diagnosis of solid lesions located at the pancreatic head.
    Liao Q, Zhao YP, Yang YC, Li LJ, Long X, Han SM.
    Hepatobiliary Pancreat Dis Int; 2007 Dec; 6(6):641-5. PubMed ID: 18086633
    [Abstract] [Full Text] [Related]

  • 6. CEACAM1, a novel serum biomarker for pancreatic cancer.
    Simeone DM, Ji B, Banerjee M, Arumugam T, Li D, Anderson MA, Bamberger AM, Greenson J, Brand RE, Ramachandran V, Logsdon CD.
    Pancreas; 2007 May; 34(4):436-43. PubMed ID: 17446843
    [Abstract] [Full Text] [Related]

  • 7. Analysis of serum catalase activities in pancreatic diseases.
    Fukui M, Kanoh M, Takamatsu Y, Arakawa Y.
    J Gastroenterol; 2004 May; 39(5):469-74. PubMed ID: 15175946
    [Abstract] [Full Text] [Related]

  • 8. Tumor marker M2-pyruvate-kinase in differential diagnosis of chronic pancreatitis and pancreatic cancer.
    Novotný I, Dítĕ P, Dastych M, Záková A, Trna J, Novotná H, Nechutová H.
    Hepatogastroenterology; 2008 May; 55(85):1475-7. PubMed ID: 18795715
    [Abstract] [Full Text] [Related]

  • 9. [Arginase activity in blood serum of patients with acute and chronic pancreatitis].
    Scibior D, Ashamiss F, Wierzbicki Z, Barańczyk-Kuźma A.
    Pol Merkur Lekarski; 2006 Dec; 21(126):522-4. PubMed ID: 17405289
    [Abstract] [Full Text] [Related]

  • 10. Serum Carboxypeptidase Activity and Genotype-Stratified CA19-9 to Detect Early-Stage Pancreatic Cancer.
    Tanaka H, Tamura K, Abe T, Yoshida T, Macgregor-Das A, Dbouk M, Blackford AL, Borges M, Lennon AM, He J, Burkhart R, Canto MI, Goggins M.
    Clin Gastroenterol Hepatol; 2022 Oct; 20(10):2267-2275.e2. PubMed ID: 34648951
    [Abstract] [Full Text] [Related]

  • 11. Neopterin--a potential factor for differentiation between pancreatic cancer and chronic pancreatitis.
    Piecuch J, Rudzki M, Orkisz W, Swietochowska E, Wielkoszyński T, Waniczek D, Arendt J, Sosada K, Zurawiński W, Ładny JR.
    Hepatogastroenterology; 2008 Oct; 55(81):258-61. PubMed ID: 18507120
    [Abstract] [Full Text] [Related]

  • 12. Tumor markers in staging and prognosis of colorectal carcinoma.
    Levy M, Visokai V, Lipska L, Topolcan O.
    Neoplasma; 2008 Oct; 55(2):138-42. PubMed ID: 18237252
    [Abstract] [Full Text] [Related]

  • 13. Application of C12 multi-tumor marker protein chip in the diagnosis of gastrointestinal cancer: results of 329 surgical patients and suggestions for improvement.
    Yang XQ, Yan L, Chen C, Hou JX, Li Y.
    Hepatogastroenterology; 2009 Oct; 56(94-95):1388-94. PubMed ID: 19950797
    [Abstract] [Full Text] [Related]

  • 14. S100A6 is increased in a stepwise manner during pancreatic carcinogenesis: clinical value of expression analysis in 98 pancreatic juice samples.
    Ohuchida K, Mizumoto K, Yu J, Yamaguchi H, Konomi H, Nagai E, Yamaguchi K, Tsuneyoshi M, Tanaka M.
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):649-54. PubMed ID: 17416753
    [Abstract] [Full Text] [Related]

  • 15. Serum Sialyl Lewis x and cytokeratin 19 fragment as predictive factors for recurrence in patients with stage I non-small cell lung cancer.
    Mizuguchi S, Nishiyama N, Iwata T, Nishida T, Izumi N, Tsukioka T, Inoue K, Uenishi T, Wakasa K, Suehiro S.
    Lung Cancer; 2007 Dec; 58(3):369-75. PubMed ID: 17697728
    [Abstract] [Full Text] [Related]

  • 16. Identification of Cystatin SN as a novel tumor marker for colorectal cancer.
    Yoneda K, Iida H, Endo H, Hosono K, Akiyama T, Takahashi H, Inamori M, Abe Y, Yoneda M, Fujita K, Kato S, Nozaki Y, Ichikawa Y, Uozaki H, Fukayama M, Shimamura T, Kodama T, Aburatani H, Miyazawa C, Ishii K, Hosomi N, Sagara M, Takahashi M, Ike H, Saito H, Kusakabe A, Nakajima A.
    Int J Oncol; 2009 Jul; 35(1):33-40. PubMed ID: 19513549
    [Abstract] [Full Text] [Related]

  • 17. PAM4-reactive MUC1 is a biomarker for early pancreatic adenocarcinoma.
    Gold DV, Karanjawala Z, Modrak DE, Goldenberg DM, Hruban RH.
    Clin Cancer Res; 2007 Dec 15; 13(24):7380-7. PubMed ID: 18094420
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Pancreatic elastase 1].
    Ogawa M.
    Rinsho Byori; 2001 Nov 15; Suppl 116():131-4. PubMed ID: 11797373
    [Abstract] [Full Text] [Related]

  • 20. Protein profiling in pancreatic juice for detection of intraductal papillary mucinous neoplasm of the pancreas.
    Shirai Y, Sogawa K, Yamaguchi T, Sudo K, Nakagawa A, Sakai Y, Ishihara T, Sunaga M, Nezu M, Tomonaga T, Miyazaki M, Saisho H, Nomura F.
    Hepatogastroenterology; 2008 Nov 15; 55(86-87):1824-9. PubMed ID: 19102401
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.